ArticleCase reports in oncology

Switching from Zoledronic Acid to Denosumab for Bone Modification Therapy in Patients with Malignant Tumors and Renal Insufficiency: A Retrospective Case Series and Literature Review.

Junmei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.